0001683168-21-005204.txt : 20211102
0001683168-21-005204.hdr.sgml : 20211102
20211102215142
ACCESSION NUMBER: 0001683168-21-005204
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211029
FILED AS OF DATE: 20211102
DATE AS OF CHANGE: 20211102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MITRANI MARIA INES
CENTRAL INDEX KEY: 0001690319
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55008
FILM NUMBER: 211373514
MAIL ADDRESS:
STREET 1: 4045 SHERIDAN AVE.
STREET 2: SUITE 239
CITY: MIAMI
STATE: FL
ZIP: 33140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Organicell Regenerative Medicine, Inc.
CENTRAL INDEX KEY: 0001557376
STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS TRANSPORTATION EQUIPMENT [3790]
IRS NUMBER: 474180540
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1031
BUSINESS ADDRESS:
STREET 1: 4045 SHERIDAN AVENUE
STREET 2: SUITE 239
CITY: MIAMI
STATE: FL
ZIP: 33140
BUSINESS PHONE: 888-963-7881
MAIL ADDRESS:
STREET 1: 4045 SHERIDAN AVENUE
STREET 2: SUITE 239
CITY: MIAMI
STATE: FL
ZIP: 33140
FORMER COMPANY:
FORMER CONFORMED NAME: Biotech Products Services & Research, Inc.
DATE OF NAME CHANGE: 20150917
FORMER COMPANY:
FORMER CONFORMED NAME: BESPOKE TRICYCLES INC
DATE OF NAME CHANGE: 20120831
4
1
ownership.xml
X0306
4
2021-10-29
0
0001557376
Organicell Regenerative Medicine, Inc.
BPSR
0001690319
MITRANI MARIA INES
4045 SHERIDAN AVENUE, SUITE 239
MIAMI
FL
33140
0
1
0
0
Chief Science Officer
Common Stock
2021-10-29
4
J
0
15000000
D
101707890
D
Common Stock
2021-10-29
4
J
0
15000000
A
116707890
D
Common Stock
166790190
I
Additional shares held by spouse
The shares of common stock of Organicell Regenerative Medicine, Inc., a Nevada corporation (the "Company") were disposed of and acquired, respectively, pursuant to an Exchange Agreement dated October 29, 2021 (the "Agreement"), whereby the Reporting Person exchanged shares of common stock of the Company previously issued under the Organicell Regenerative Medicine, Inc. Management and Consultants Performance Stock Plan for shares of common stock of the Company in the Organicell Regenerative Medicine, Inc. 2021 Equity Incentive Plan. The newly issued shares shall vest on December 31, 2023.
Received in exchange for the Company's common stock on a 1:1 basis. This exchange was completed in connection with the Agreement.
The total number of shares of common stock owned collectively by Maria Ines Mitrani and Albert Mitrani is 283,498,080.
/s/ Maria Ines Mitrani
2021-11-02